SKA1 and hepatocellular carcinoma: An immunohistochemical study of 126 hepatocellular carcinoma patients revealed that SKA1 expression is significantly elevated in tumor tissues, and it can regulate the hepatocellular carcinoma cell cycle and contributes to poor prognosis (63).